Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Senior Appointments

30 Mar 2010 12:37

RNS Number : 4219J
W.H. Ireland Group PLC
30 March 2010
 



WH Ireland Group Plc

 

Appointment of New Heads of Institutional Sales/Trading and Corporate Finance

 

WH Ireland Group plc (AIM:WHI), the financial services group, is delighted to announce two senior appointments to lead its Institutional Sales/Trading and Corporate Finance operations. Both will be joining in the week commencing 12 April 2010.

 

Russell Hooper joins as Head of Institutional Sales/Trading and will be responsible for coordinating the Group's institutional stockbroking business. Previously, Russell has been Head of European Institutional Client Sales Trading and also Head of Pan European Hedge Fund Sales Trading at Merrill Lynch where he spent 15 years in the Institutional Equities division. He graduated in Materials Engineering from Cardiff University. His interests include cricket, rugby (Welsh) and cycling.

 

Chris Fielding joins as Head of Corporate Finance, bringing with him over 20 years' experience in corporate finance as a small/mid cap specialist. Since 2005, Chris has worked at Arden Partners, having previously spent eleven years at Hoare Govett, where he was a director of Corporate Finance. He qualified as a chartered accountant with Price Waterhouse. Chris will be based in the Group's London office and will lead the continued expansion of the corporate finance business. Chris' interests and hobbies include rugby (English), skiing, classic cars, travel and walking.

 

The WH Ireland team already has significant depth of experience and strong regional coverage through John Wakefield (Bristol), Dan Bate (Manchester), James Joyce (London) and their respective teams, supported by the Group's award-winning research team, based in Leeds, headed by Matthew Davis. In line with the Group's strategy, these appointments will further enhance WH Ireland's institutional sales and corporate finance offering.

 

Commenting on the appointments, Richard Ford (CEO) said:

 

"We are delighted to have secured the services of two top calibre individuals both of whom bring substantial skill and experience to the firm. These appointments come at a time when we are seeing a significant uplift in client demand for our corporate stockbroking services where we are looking to build our already strong position in the market. Russell and Chris will continue to drive our business forward and complement our existing Securities business both in London and through our principal regional offices in Manchester, Leeds, Birmingham and Bristol."

 

John Wakefield commented:

 

"The two appointments continue the work already in place to address the aspirations of our corporate client base to gain wider access to sources of capital and to benefit from best of breed advice in our core small/mid cap market."

 

Matthew Davis (Head of Institutional Research) said of the appointments:

 

"Both Chris and Russell bring significant experience, further enhancing WH Ireland's distribution capability, both corporately and institutionally."

 

30 March 2010

 

Enquiries:

 

WH Ireland Tel: 020 7220 1666

Richard Ford

 

Biddicks (Financial PR to WH Ireland) Tel: 020 7448 1000

Zoe Biddick

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFMGFFMGDGGZM
Date   Source Headline
17th Nov 202512:58 pmRNSForm 8.3 - W.H. Ireland Group PLC
14th Nov 202510:13 amRNSForm 8 (DD)
13th Nov 20259:39 amRNSForm 8.3 - WH Ireland Group plc
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
5th Nov 20257:00 amRNSDirectorate Change
29th Oct 20257:00 amRNSDeferred Consideration re Capital Markets Division
27th Oct 20252:51 pmRNSResult of GM
27th Oct 20257:00 amRNSDirectorate Change
20th Oct 20251:49 pmRNSAdjournment of GM
16th Oct 20259:24 amRNSHolding(s) in Company
16th Oct 20259:23 amRNSHolding(s) in Company
9th Oct 20253:07 pmRNSResult of General Meeting
8th Oct 202510:21 amRNSResponse to Press Speculation
30th Sep 20253:23 pmRNSResult of AGM
26th Sep 20254:14 pmRNSFinal Results, Notice of GM and Annual Report
22nd Sep 20257:26 amRNSConditional disposal of Wealth Management Business
5th Sep 20257:00 amRNSNotice of AGM
10th Feb 20257:00 amRNSHenley Office
17th Dec 20241:17 pmRNSHolding(s) in Company
13th Dec 20247:04 amRNSInterim Results
17th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSNominated Adviser Status
30th Sep 20244:08 pmRNSResult of AGM
10th Sep 20249:51 amRNSHolding(s) in Company
30th Aug 202412:00 pmRNSNotice of AGM and Publication of Annual Report
22nd Aug 20245:46 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSCompletion of Sale of the Capital Markets Division
27th Jun 20246:19 pmRNSHolding(s) in Company
27th Jun 20246:17 pmRNSHolding(s) in Company
26th Jun 202410:26 amRNSConfirmation of Chair Appointment
21st Jun 20248:09 amRNSDirector Notification
3rd Jun 20247:00 amRNSSale of Capital Markets Division & Trading Update
20th May 202411:14 amRNSResponse to Press Speculation
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.